Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Cordycepin Against Pulmonary Arterial Hypertension

DOI:10.4121/20502675.v2
The DOI displayed above is for this specific version of this dataset, which is currently the latest. Newer versions may be published in the future. For a link that will always point to the latest version, please use
DOI: 10.4121/20502675

Datacite citation style

Jiangpeng Lin (2023): Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Cordycepin Against Pulmonary Arterial Hypertension. Version 2. 4TU.ResearchData. dataset. https://doi.org/10.4121/20502675.v2
Other citation styles (APA, Harvard, MLA, Vancouver, Chicago, IEEE) available at Datacite

Dataset

Version 2 - 2023-06-07 (latest)
Version 1 - 2022-08-22

This study identified the potential targets of Cordycepin against PAH using network pharmacology and in vitro verification, which provided a new understanding of the pharmacological mechanisms of Cordycepin in treatment of PAH.


History

  • 2022-08-22 first online
  • 2023-06-07 published, posted

Publisher

4TU.ResearchData

Format

image/jpg ,g-zipped files. xlxs

Funding

  • the Natural Science Foundation of Guangdong Province(No. 2021A1515011373)

Organizations

Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China.

DATA

Files (13)